

Is Daptomycin still in shortage in 2026? Get the latest update on availability, pricing, and what patients can do to find it.
If you or a loved one relies on Daptomycin (Cubicin) to treat a serious bacterial infection, you've likely heard about — or experienced firsthand — difficulties finding it. Daptomycin has been affected by intermittent supply disruptions in recent years, leaving patients and hospitals scrambling for this critical antibiotic.
In this update, we'll cover the current shortage status, why Daptomycin remains hard to find, what it costs in 2026, and what you can do to secure your prescription.
As of early 2026, Daptomycin continues to experience supply variability. While it's not always listed as an active shortage on the FDA or ASHP databases, real-world availability — particularly for certain formulations and from specific manufacturers — remains inconsistent.
Here's what that means for patients:
The ASHP Drug Shortages Resource Center tracks antibiotics like Daptomycin in real time. We also recommend using Medfinder to check which pharmacies near you currently have Daptomycin in stock.
Several factors contribute to the ongoing supply challenges with Daptomycin:
Daptomycin is a cyclic lipopeptide antibiotic derived from a soil bacterium (Streptomyces roseosporus). Its manufacturing process is more complex than typical antibiotics, involving fermentation and specialized purification steps. Any disruption in this process can lead to production delays.
While generic Daptomycin is available, the number of active manufacturers remains relatively small. When even one manufacturer experiences quality issues or production shutdowns, the market feels the impact quickly.
Antibiotic-resistant infections — especially MRSA — continue to grow. As more patients need potent antibiotics like Daptomycin that work against resistant bacteria, demand has outpaced supply in some periods.
As an IV-only medication, Daptomycin flows through a different supply chain than oral drugs. It's distributed primarily to hospitals, specialty pharmacies, and home infusion companies rather than retail pharmacies. This makes it harder for individual patients to track down. For a detailed explanation, read why Daptomycin is so hard to find.
The cost of Daptomycin varies significantly depending on whether you're getting the brand or generic version:
If cost is a concern, check out our complete guide on how to save money on Daptomycin, which covers discount programs, patient assistance, and insurance strategies.
In recent years, the availability of premixed Daptomycin IV solutions has expanded. These ready-to-use bags eliminate the need for pharmacies to reconstitute the lyophilized powder, which can be more convenient for home infusion patients and may have separate supply from the traditional vials.
Additionally, the number of FDA-approved generic manufacturers has grown since Cubicin's patent expired, which should continue to improve supply over time.
If Daptomycin remains unavailable for your situation, there are alternative antibiotics your doctor may consider, including Vancomycin, Linezolid, Telavancin, and Oritavancin.
Here are the most effective steps you can take:
For a complete walkthrough, see our guide on how to find Daptomycin in stock near you.
Daptomycin remains a critical weapon against some of the most dangerous antibiotic-resistant infections. While supply challenges persist in 2026, the situation is improving as more generic manufacturers enter the market and premixed formulations become more widely available.
Stay proactive: use Medfinder to monitor availability, work closely with your infectious disease doctor, and explore all formulation options. If you're a healthcare provider, our provider shortage guide has additional resources and strategies.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.